Provided by Tiger Trade Technology Pte. Ltd.

ProShares Ultra Nasdaq Biotechnology

119.66
-2.5041-2.05%
Volume:6K
Turnover:681.43K
Market Cap:101.71M
PE:- -
High:123.15
Open:123.00
Low:118.50
Close:122.16
52wk High:126.40
52wk Low:54.56
Shares:850.00K
Float Shares:850.00K
Volume Ratio:0.69
T/O Rate:0.67%
Dividend:0.32
Dividend Rate:0.27%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Gilead Sciences Delivers 'Plenty' to Like in Q2, RBC Says

MT Newswires Live
·
Aug 06

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Staar Surgical (STAA) and Elanco Animal Health (ELAN)

TIPRANKS
·
Aug 06

Gilead Sciences Inc Stock (GILD) Moved Down by 3.96% on Aug 5: A Full Analysis

TradingKey
·
Aug 06

Gilead Sciences (GILD) Faces Fresh HIV Access Criticism From AIDS Healthcare Foundation

Simply Wall St.
·
Aug 05

Amgen is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Aug 05

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-05

Reuters
·
Aug 05

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Ultragenyx Pharmaceutical (RARE) and Beam Therapeutics (BEAM)

TIPRANKS
·
Aug 05

Amgen Jolts to Record-High After Hiking FY Forecasts, Q2 Results Beat

Reuters
·
Aug 05

Amgen Shares Hit Record High; Last up 6.3% at $414.61

THOMSON REUTERS
·
Aug 05

Amgen Shares up 5% After Q2 Results Beat Estimates; FY Profit Forecast Raise

THOMSON REUTERS
·
Aug 05

Dow's 500-Point Rally Led by Gains in Amgen, Nvidia Corp. Shares

Dow Jones
·
Aug 05

Amgen Inc : Canaccord Genuity Raises Target Price to $384 from $366

THOMSON REUTERS
·
Aug 05

Immuneering Expects Cash Runway to Fund Operations into 2029

Reuters
·
Aug 05

Analysts Offer Insights on Healthcare Companies: Exagen (XGN), Amgen (AMGN) and Arvinas Holding Company (ARVN)

TIPRANKS
·
Aug 05

Kymera Therapeutics Q2 Collaboration Revenue More than Doubles, Beats Estimates

Reuters
·
Aug 05

Gilead : Leerink Partners Raises Target Price to $130 from $126

THOMSON REUTERS
·
Aug 05

Amgen Inc : Scotiabank Raises Target Price to $450 from $385

THOMSON REUTERS
·
Aug 05

Gilead Sciences (GILD) Gets a Buy from Wells Fargo

TIPRANKS
·
Aug 05

Gilead Buy Rating Reaffirmed on Strong HIV-Driven Growth and Raised Revenue Outlook; $170 Price Target Maintained

TIPRANKS
·
Aug 05

Street View: Gilead's HIV Strength Outshines Long-Term Competitive Worries

Reuters
·
Aug 05